← SynDRA
GW-788388
SynDRA canonical compound SYN0055898 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | LCK | MAPK14 | TGFBR1 |
| Mechanism of action | ALK tyrosine kinase receptor inhibitor |
All known targets
Mechanisms of action (all sources)
- ALK tyrosine kinase receptor inhibitor
- LCK INHIBITOR
- MAPK14 INHIBITOR
- TGFBR1 INHIBITOR
Cross-references
Synonyms
- CPD 13D
- GW788388
- GW 788388
- 4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide
- UNII-N14114957J
- CHEMBL202887
- N14114957J
- 4-[4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl]-N-(tetrahydropyran-4-yl)benzamide
- N-(oxan-4-yl)-4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}benzamide
- 4-(4-(3-(Pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydropyran-4-yl)benzamide
- cc-69
- SCHEMBL373524
- SCHEMBL17926774
- CTK8C0589
- DTXSID70196444
- EX-A122
- AOB2606
- RefChem:144820
- MFCD16038936
- orb1307416
- SCHEMBL29358505
- SCHEMBL29438747
- SCHEMBL29521554
- GLXC-04575
- HMS3656N21
- BDBM50184872
- s2750
- AKOS016005022
- AKOS026750217
- CCG-268948
- CS-0254
- EBC-220144
- SB19488
- NCGC00346679-01
- NCGC00346679-04
- NCGC00346679-10
- NCGC00346679-12
- AC-31390
- AS-74347
Look up GW-788388 in the interactive SynDRA portal →